Introduction and Objective: Diabetes mellitus (DM) is a chronic condition characterized by elevated blood glucose levels due to insufficient insulin production or ineffective utilization. DM often coexists with thyroid diseases, particularly hypothyroidism, which can impact glycemic control and increase the risk of complications. Thyroid replacement therapy, typically with levothyroxine, is crucial for managing hypothyroidism in diabetic patients. This study analyzes the prescription trends of thyroid replacement therapy in the diabetic population in Spain from 2018 to 2023Methods: A retrospective analysis of thyroid replacement therapy prescriptions in diabetic individuals was conducted using data from BDCAP (Primary Care Clinical DataBase), categorized by gender and age groups (00-14, 15-34, 35-54, 65 and above). The total number of cases and the rate per thousand individuals treated were calculatedResults: Data reveals a steady increase in thyroid replacement therapy prescriptions over the five-year period. In 2018, the prescription rates were notably higher in females compared to males, a trend that continued through 2023. Women, particularly those aged 65 and above, consistently showed the highest prescription rates throughout the study period. This trend highlights a significant gender and age disparity in the prescription of thyroid replacement therapy among diabetic patientsConclusion: The prescription of thyroid replacement therapy in the diabetic population has significantly increased over the last 5 years, with a higher prevalence in women aged 65 and above. These findings suggest a growing trend towards thyroid treatment in diabetes management. Further prospective studies are recommended to evaluate the efficacy and safety of this practice.
J. Ares: None. E. Menéndez-Torre: Speaker’s Bureau; Abbott Diagnostics, Sanofi. Advisory Panel; Insulocloud.
Source link
Leave a Reply